Pharmaceutical Preparations · CIK 849146
LifeVantage develops and sells scientifically validated nutrigenomic products and supplements through a direct sales model
Comparable business profile · signals at a glance
In the 90 days to Mar 16, 2026: 2 insiders bought $179K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 16, 2026 | Lewis DarwinDirector | Buy | 1,055 | $5.23 | $6K |
| Mar 2, 2026 | Dayton JuddDirector | Buy | 10,500 | $4.53 | $48K |
| Feb 27, 2026 | Dayton JuddDirector | Buy | 18,097 | $4.63 | $84K |
| Feb 26, 2026 | Dayton JuddDirector | Buy | 4,600 | $4.58 | $21K |
| Feb 9, 2026 | Lewis DarwinDirector | Buy | 3,955 | $5.22 | $21K |
| Dec 15, 2025 | Lewis DarwinDirector | Buy | 805 | $6.54 | $5K |
| Nov 19, 2025 | Beindorff Michael ADirector | Sell | 12,607 | $6.42 | $81K |
| Nov 7, 2025 | Beindorff Michael ADirector | Sell | 35,000 | $6.92 | $242K |
| Nov 7, 2025 | Beindorff Michael ADirector | Sell | 1,000 | $7.33 | $7K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.